EXTL2 抗体 (AA 5-110) (Cy7)
Our Local Distributor
北京 101111
Quick Overview for EXTL2 抗体 (AA 5-110) (Cy7) (ABIN761057)
抗原
See all EXTL2 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 5-110
-
预测反应
- Human,Mouse,Rat,Dog,Sheep,Pig,Horse,Rabbit
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human EXTL
-
亚型
- IgG
-
-
anti-Exostoses (Multiple)-Like 2 (EXTL2) (AA 39-330) antibody
EXTL2 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
anti-Exostoses (Multiple)-Like 2 (EXTL2) (AA 1-330) antibodyEXTL2 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
anti-Exostoses (Multiple)-Like 2 (EXTL2) (AA 39-330) antibodyEXTL2 适用: 人 WB 宿主: 小鼠 Polyclonal unconjugated
anti-Exostoses (Multiple)-Like 2 (EXTL2) (AA 1-330) antibodyEXTL2 适用: 人 WB 宿主: 小鼠 Polyclonal unconjugated
anti-Exostoses (Multiple)-Like 2 (EXTL2) (AA 269-295), (C-Term) antibodyEXTL2 适用: 人, 小鼠 WB 宿主: 兔 Polyclonal RB23786 unconjugated
anti-Exostoses (Multiple)-Like 2 (EXTL2) (AA 280-310), (C-Term) antibodyEXTL2 适用: 人, 小鼠 WB, EIA 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
有效期
- 12 months
-
-
- EXTL2 (Exostoses (Multiple)-Like 2 (EXTL2))
-
别名
- EXTL2
-
背景
-
Synonyms: Alpha 1 4 N acetylhexosaminyltransferase EXTL2, Alpha GalNAcT EXTL2, Exostoses multiple like 2, Exostoses multiple like 2, Exostosin like 2, EXT L2, EXT related protein 2, EXTL 2, EXTR 2, EXTR2, Glucuronyl galactosyl proteoglycan 4 alpha N acetylglucosaminyltransferase, Multiple exostoses like 2, Processed exostosin like 2, EXTL2_HUMAN.
Background: EXTL2 is a glycosyltransferase required for the biosynthesis of heparan-sulfate and is responsible for the alternating addition of beta-1-4-linked glucuronic acid (GlcA) and alpha-1-4-linked N-acetylglucosamine (GlcNAc) units to nascent heparan sulfate chains.
-
基因ID
- 2134
抗原
-
